These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4281970)

  • 1. [Treatment of progressive scleroderma using carnitine].
    Schneider D
    Z Gesamte Inn Med; 1974 Jul; 29(13):544-9. PubMed ID: 4281970
    [No Abstract]   [Full Text] [Related]  

  • 2. [Observations of the course of scleroderma after combined Hylase-carnitine therapy].
    Nitzschner H
    Z Arztl Fortbild (Jena); 1975 Nov; 69(21):1108. PubMed ID: 1226844
    [No Abstract]   [Full Text] [Related]  

  • 3. Scleroderma treated with low molecular weight dextran.
    Fountain RB; Stevens A
    Br J Dermatol; 1966 Nov; 78(11):605-6. PubMed ID: 5921443
    [No Abstract]   [Full Text] [Related]  

  • 4. [The course of scleroderma following treatment with carnitin].
    Nitzschner H
    Dermatol Monatsschr; 1974 Jul; 160(7):592-6. PubMed ID: 4411133
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of scleroderma].
    Holzmann H; Korting GW
    Dtsch Med Wochenschr; 1968 Sep; 93(36):1721-2. PubMed ID: 5668267
    [No Abstract]   [Full Text] [Related]  

  • 6. [Gestagens in the treatment of scleroderma].
    Szczepański A
    Przegl Dermatol; 1973; 60(4):521-3. PubMed ID: 4755917
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of carnitine in connective tissue diseases].
    Nitzschner H; Liebsch F
    Dermatol Monatsschr; 1971 Jul; 157(7):538-42. PubMed ID: 5116603
    [No Abstract]   [Full Text] [Related]  

  • 8. [Dextran-therapy in diffuse (progressive) scleroderma].
    Balda BR; Christophers E
    Hautarzt; 1970 Mar; 21(3):131-2. PubMed ID: 5520814
    [No Abstract]   [Full Text] [Related]  

  • 9. [Carnitine and diseases of the connective tissue].
    Strack E; Nitschner H; Liebsch F
    Dtsch Gesundheitsw; 1970 Jun; 25(26):1233-6. PubMed ID: 5515092
    [No Abstract]   [Full Text] [Related]  

  • 10. Stimulating circulation to end stasis in scleroderma.
    Yuan X; Li JD; Chen WJ; Li ZS; Zhu HT; Liu JW; Zhu MJ
    Chin Med J (Engl); 1981 Feb; 94(2):85-93. PubMed ID: 6786844
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical and experimental study of the method of activating blood circulation and relieving blood stasis in the treatment of scleroderma].
    Qin WZ
    Zhong Xi Yi Jie He Za Zhi; 1981 Oct; 1(2):69-71. PubMed ID: 6219780
    [No Abstract]   [Full Text] [Related]  

  • 12. [Results of 100-day treatment of generalized scleroderma with imuran].
    Czernielewski A; Olszewska Z
    Przegl Dermatol; 1973; 60(6):761-7. PubMed ID: 4769960
    [No Abstract]   [Full Text] [Related]  

  • 13. Carnitine deficiency in scleroderma.
    Famularo G; De Simone C; Danese C
    Immunol Today; 1999 May; 20(5):246. PubMed ID: 10322305
    [No Abstract]   [Full Text] [Related]  

  • 14. Bosentan improves systemic sclerosis-related peripheral circulation insufficiency.
    Yagi S; Akaike M; Aihara K; Iwase T; Sumitomo-Ueda Y; Yoshida S; Matsumoto T; Sata M
    Int J Cardiol; 2011 Mar; 147(3):472-5. PubMed ID: 21296436
    [No Abstract]   [Full Text] [Related]  

  • 15. [A contribution to the effects of synthetic progesterone on systemic scleroderma (author's transl)].
    Ishikawa H; Tamura T; Horiuchi R; Tuihiji T; Ishii Y
    Nihon Hifuka Gakkai Zasshi; 1975 Apr; 85(5):299-301. PubMed ID: 125813
    [No Abstract]   [Full Text] [Related]  

  • 16. Rheomacrodex in the treatment of scleroderma.
    Tonkin JR
    Australas J Dermatol; 1968 Jun; 9(3):240-3. PubMed ID: 5673930
    [No Abstract]   [Full Text] [Related]  

  • 17. Colchicine in the treatment of scleroderma.
    Guttadauria M; Diamond H; Kaplan D
    J Rheumatol; 1977; 4(3):272-6. PubMed ID: 926103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scleroderma treated with dextran 40 (Rheomacrodex).
    Katz D; Kantor I
    Arch Dermatol; 1966 Nov; 94(5):675-7. PubMed ID: 5960381
    [No Abstract]   [Full Text] [Related]  

  • 19. [Low-molecular dextran (40,000) in the treatment of scleroderma].
    Szczepański A; Zielińska Z; Polkowska M; Lorenc B
    Przegl Dermatol; 1975; 62(1):79-82. PubMed ID: 1111035
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of scleroderma by Rheomacrodex.
    Alani MD
    Acta Derm Venereol; 1970; 50(2):137-9. PubMed ID: 4192318
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.